Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

And one final great grep feature: recursive search. Running “grep -r pattern” will search all files within your current ...

Derek's love of games came at an early age when his parents first brought home the Nintendo Entertainment System. From then on, countless nights were spent hunting ducks, stomping turtles, exploring ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

In the latest close session, Recursion Pharmaceuticals (RXRX) was down 5.42% at $5.23. The stock fell short of the S&P 500, which registered a loss of 0.38% for the day. Meanwhile, the Dow experienced ...

From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that ...

No one can say with scientific confidence why we exist or what happens when we die. In fact, scientists have a tenuous grasp on what it even means to be conscious. But our purely human urge to ask the ...

MONTGOMERY, Ala. (WSFA) - New laws took effect in Alabama at the start of the month and last session’s Senate Bill 101 is among them. One raised the medical age of consent from age 14 to 16, which ...

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Listen to more stories on the Noa app. Want to stay current with Arthur’s writing? Sign up to get an email every time a new column comes out. In a recent column, I wrote about the morning protocol I ...